chrX:40580894:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chrX:40,440,146-40,466,100 |
| hg38 | chrX:40,580,894-40,606,848 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
| <0.001 | Crohn Disease | NA | BeFree | Detail | |
| <0.001 | Dermatitis, Atopic | NA | BeFree | Detail | |
| 0.001 | Diabetes | NA | BeFree | Detail | |
| 0.001 | diabetes mellitus | NA | BeFree | Detail | |
| <0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
| <0.001 | Diabetic Nephropathy | NA | BeFree | Detail | |
| <0.001 | diabetic retinopathy | NA | BeFree | Detail | |
| <0.001 | Eczema | NA | BeFree | Detail | |
| 0.120 | Fibrosis | NA | CTD_human | Detail | |
| 0.120 | IgA glomerulonephritis | NA | CTD_human | Detail | |
| <0.001 | hepatitis B | NA | BeFree | Detail | |
| 0.005 | Hypertensive disease | Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 att... | BeFree,GAD | 25421983 | Detail |
| <0.001 | Immune System Diseases | NA | BeFree | Detail | |
| <0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
| <0.001 | Kidney Diseases | NA | BeFree | Detail | |
| <0.001 | Kidney Failure, Chronic | NA | BeFree | Detail | |
| <0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
| <0.001 | lymphoma | We attempted to explore the association of the renin-angiotensin system (RAS) an... | BeFree | 25503453 | Detail |
| <0.001 | Mycoses | Research undertaken over the last decade has uncovered critical roles of CD5L as... | BeFree | 26048980 | Detail |
| <0.001 | obesity | Impact of the prorenin/renin receptor on the development of obesity and associat... | BeFree | 25044950 | Detail |
| <0.001 | psoriasis | NA | BeFree | Detail | |
| <0.001 | kidney failure | NA | BeFree | Detail | |
| <0.001 | Dermatologic disorders | NA | BeFree | Detail | |
| <0.001 | Vascular Diseases | NA | BeFree | Detail | |
| <0.001 | Left Ventricular Hypertrophy | NA | BeFree | Detail | |
| <0.001 | renal fibrosis | NA | BeFree | Detail | |
| <0.001 | Glomerulosclerosis (disorder) | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of lung | Recently, PRR(L) was reported to enhance proliferation of breast and lung cancer... | BeFree | 26058814 | Detail |
| <0.001 | age related macular degeneration | NA | BeFree | Detail | |
| <0.001 | Infarction, Lacunar | NA | BeFree | Detail | |
| 0.005 | Hypertensive disease | Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (p... | BeFree | 21157371 | Detail |
| <0.001 | Vascular Diseases | Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (p... | BeFree | 21157371 | Detail |
| <0.001 | coronary artery disease | Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (p... | BeFree | 21157371 | Detail |
| 0.120 | Craniofacial Abnormalities | NA | CTD_human | Detail | |
| <0.001 | Chronic Kidney Insufficiency | NA | BeFree | Detail | |
| <0.001 | Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | breast carcinoma | CAPER, a novel regulator of human breast cancer progression. | BeFree | 24621503 | Detail |
| <0.001 | Carcinoma of lung | Recently, PRR(L) was reported to enhance proliferation of breast and lung cancer... | BeFree | 26058814 | Detail |
| <0.001 | Diabetic Cardiomyopathies | NA | BeFree | Detail | |
| <0.001 | Invasive Ductal Breast Carcinoma | In contrast, CAPER was expressed at higher levels in ductal carcinoma in situ (D... | BeFree | 24621503 | Detail |
| <0.001 | Aortic valve disorder | NA | BeFree | Detail | |
| <0.001 | Cardiac fibrosis | NA | BeFree | Detail | |
| <0.001 | Cardiomyopathy, Familial Idiopathic | In contrast, CAPER was expressed at higher levels in ductal carcinoma in situ (D... | BeFree | 24621503 | Detail |
| <0.001 | Chronic Kidney Diseases | NA | BeFree | Detail | |
| <0.001 | coronary artery disease | NA | BeFree | Detail | |
| <0.001 | liver carcinoma | In a panel of HCC cell lines, PRR(L) generally promotes and PRR(S) suppresses pr... | BeFree | 26058814 | Detail |
| <0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
| <0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | aortic valve disease 2 | NA | BeFree | Detail | |
| <0.001 | aortic valve insufficiency | NA | BeFree | Detail | |
| <0.001 | aortic valve stenosis | NA | BeFree | Detail | |
| <0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
| <0.001 | Autoimmune Diseases | TLR2, a PRR, recognizes exogenous PAMPs, and endogenous damage-associated molecu... | BeFree | 26079624 | Detail |
| <0.001 | Malignant neoplasm of breast | CAPER, a novel regulator of human breast cancer progression. | BeFree | 24621503 | Detail |
| <0.001 | candidiasis | NA | BeFree | Detail | |
| <0.001 | Candidiasis, Chronic Mucocutaneous | NA | BeFree | Detail | |
| <0.001 | Noninfiltrating Intraductal Carcinoma | In contrast, CAPER was expressed at higher levels in ductal carcinoma in situ (D... | BeFree | 24621503 | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycortico... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We attempted to explore the association of the renin-angiotensin system (RAS) and (pro)renin recepto... | DisGeNET | Detail |
| Research undertaken over the last decade has uncovered critical roles of CD5L as a PRR of bacterial ... | DisGeNET | Detail |
| Impact of the prorenin/renin receptor on the development of obesity and associated cardiometabolic r... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Recently, PRR(L) was reported to enhance proliferation of breast and lung cancer cells. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (pro)renin receptor (r... | DisGeNET | Detail |
| Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (pro)renin receptor (r... | DisGeNET | Detail |
| Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (pro)renin receptor (r... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CAPER, a novel regulator of human breast cancer progression. | DisGeNET | Detail |
| Recently, PRR(L) was reported to enhance proliferation of breast and lung cancer cells. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In contrast, CAPER was expressed at higher levels in ductal carcinoma in situ (DCIS) and invasive du... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In contrast, CAPER was expressed at higher levels in ductal carcinoma in situ (DCIS) and invasive du... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In a panel of HCC cell lines, PRR(L) generally promotes and PRR(S) suppresses proliferation, migrati... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| TLR2, a PRR, recognizes exogenous PAMPs, and endogenous damage-associated molecular patterns and has... | DisGeNET | Detail |
| CAPER, a novel regulator of human breast cancer progression. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In contrast, CAPER was expressed at higher levels in ductal carcinoma in situ (DCIS) and invasive du... | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs5981008 dbSNP
- Genome
- hg38
- Position
- chrX:40,580,894-40,606,848
- Variant Type
- snv
Genome browser